| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing
|
Murzyn, Aleksandra
|
|
|
94 |
2 |
p. 123-139
|
artikel
|
| 2 |
A polo-like kinase 1 inhibitor enhances erastin sensitivity in head and neck squamous cell carcinoma cells in vitro
|
Wu, Xiangping
|
|
|
94 |
2 |
p. 183-195
|
artikel
|
| 3 |
Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation
|
Ruan, Lin-jie
|
|
|
94 |
2 |
p. 169-181
|
artikel
|
| 4 |
Combined treatment of All-trans retinoic acid with Tamoxifen suppresses ovarian cancer
|
Xu, Rui
|
|
|
94 |
2 |
p. 259-270
|
artikel
|
| 5 |
Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers
|
Du, Pengfei
|
|
|
94 |
2 |
p. 251-257
|
artikel
|
| 6 |
Gene polymorphisms of TACR1 serve as the potential pharmacogenetic predictors of response to the neurokinin-1 receptor antagonist-based antiemetic regimens: a candidate-gene association study in breast cancer patients
|
Ghorbani, Marziyeh
|
|
|
94 |
2 |
p. 237-250
|
artikel
|
| 7 |
Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice
|
Deppas, Joshua J.
|
|
|
94 |
2 |
p. 271-283
|
artikel
|
| 8 |
Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia
|
Kobayashi, Takahiro
|
|
|
94 |
2 |
p. 285-296
|
artikel
|
| 9 |
PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer
|
Xu, Xianping
|
|
|
94 |
2 |
p. 209-221
|
artikel
|
| 10 |
Pharmacokinetic study of capivasertib and the CYP3A4 substrate midazolam in patients with advanced solid tumors
|
Miller, Claire
|
|
|
94 |
2 |
p. 223-235
|
artikel
|
| 11 |
Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children
|
Centanni, Maddalena
|
|
|
94 |
2 |
p. 297-310
|
artikel
|
| 12 |
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221
|
Chen, Ciao-Sin
|
|
|
94 |
2 |
p. 311-321
|
artikel
|
| 13 |
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1
|
Uryu, Kiyoaki
|
|
|
94 |
2 |
p. 197-208
|
artikel
|
| 14 |
Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients
|
Rahmayanti, Siti Utami
|
|
|
94 |
2 |
p. 141-155
|
artikel
|
| 15 |
The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers
|
Dunn, Allison
|
|
|
94 |
2 |
p. 157-167
|
artikel
|
Tijdschrift beschrijving